AzTrials
AzTrials

Calcaneus FractureNCT06888804

Posterior Tibial Nerve PRF for Painful Calcaneal Fracture

A study testing ultrasound-guided posterior tibial nerve pulsed radiofrequency in people with Calcaneus Fracture, run by Diskapi Teaching and Research Hospital at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Patients who underwent pulsed radiofrequency (PRF) treatment of the posterior tibial nerve under ultrasound guidance, which is routinely performed in our clinic for severe heel pain following a calcaneal fracture, were evaluated through interviews. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Calcaneus Fracture
What is being tested?
ultrasound-guided posterior tibial nerve pulsed radiofrequency
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteTurkey (Türkiye)
Study dates
17 Mar 2025to 30 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • History of calcaneal fracture
  • VAS score >5
  • Pain persisting for more than 3 months after the fracture

Who cannot join

  • Presence of other foot pain-causing conditions (e.g., plantar fasciitis, heel spur)
  • Additional fractures other than the calcaneus
  • Pregnancy
  • Coagulopathy or use of antiplatelet medications
  • Mental illness impairing decision-making ability

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Gokhan Yildiz contact

5059272589

gkoyldz@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Diskapi Training and Research Hospital

    Ankara

    Gevher Rabia Genç Perdecioğlu, 5332009184 ext. TR, gevhergenc@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluation of the Effectiveness of Pulsed Radiofrequency Treatment of the Posterior Tibial Nerve in the Management of Chronic Plantar Pain Due to Calcaneal Fracture

Patients who underwent pulsed radiofrequency (PRF) treatment of the posterior tibial nerve under ultrasound guidance, which is routinely performed in our clinic for severe heel pain following a calcaneal fracture, were evaluated through interviews. The assessment was conducted using the Visual Analog Scale (VAS) for pain and the American Orthopaedic Foot and Ankle Society (AOFAS) score.

Read the detailed description

Pain following a calcaneal fracture can arise from direct injury, traction injury, idiopathic mechanisms such as reflex sympathetic dystrophy/complex regional pain syndrome (CRPS), or nerve damage. Since there is no single standardized definition or diagnosis for post-surgical nerve pain, such cases are described in the literature as neurapraxia, postoperative neuroma, unexplained heel pain, hypersensitive scar, or CRPS. Typically, this type of pain manifests as burning, paresthesia, dysesthesia, and hyperesthesia.

The tibial nerve plays a crucial role in the sensory and motor innervation of the heel. Following a calcaneal fracture, direct nerve injury, compression, or inflammation of the surrounding tissues may contribute to pain. Pulsed radiofrequency (PRF) has been shown to alleviate chronic pain by delivering an electrical field to the nerve tissue at a controlled temperature of <42°C without causing nerve damage. Additionally, there is evidence supporting PRF's effectiveness in pain relief for patients with various chronic conditions.

In our study, the investigators aim to evaluate patients with persistent pain after a calcaneal fracture who have undergone PRF treatment of the posterior tibial nerve. By monitoring these patients immediately after the intervention, we will assess changes in their pain scores. Additionally, the investigators will compare them to patients with post-calcaneal fracture pain who have opted not to undergo the procedure.

Being tested
ultrasound-guided posterior tibial nerve pulsed radiofrequency, Control Group
Keywords
Pulsed Radiofrequency Treatment, Tibial Nerve

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ultrasound-guided posterior tibial nerve pulsed radiofrequencyProcedure or surgery

    The posterior tibial nerve (PTN) was identified with a 5-12 MHz linear ultrasonography (US) probe at the level of the medial malleolus, where it runs posterior to the posterior tibial artery. Using the in-plane technique, a 22-gauge, 10-cm radiofrequency cannula was inserted under US guidance and advanced until the tip was adjacent to the nerve. Pulse radiofrequency was applied at 42°C for 240 s with a pulse width of 20 ms.

  • Control GroupOther

    No intervention

Study groups in NCT06888804
Study groupRoleWhat they receive
Posterior Tibial Nerve PRF for Painful Calcaneal FractureActive comparatorposterior tibial nerve pulsed radiofrequency for painful calcaneal fracture
Receives: Procedure: ultrasound-guided posterior tibial nerve pulsed radiofrequency
ControlActive comparatorcontrol group for painful calcaneal fracture
Receives: Other: Control Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual analog scale (VAS)

    VAS is a scale that can be used measuring pain. Scores range from 0 (no pain) to 10 (the worst pain)

    Measured: Change from baseline to 3rd month after treatment

Secondary outcomes (1)
  1. The American Orthopaedic Foot and Ankle Society (AOFAS)

    The American Orthopaedic Foot and Ankle Society (AOFAS) score is evaluated under three subcategories: pain, function, and alignment. It includes both objective (function and alignment) and subjective (pain) data. Patients report their pain levels, which are then scored by physicians. Additionally, patients and doctors collaborate to complete the functional and alignment assessments.

    Scores range from 0 to 100, with 100 representing a healthy patient. This scoring system will be assessed pre-procedure, on the day of the procedure, and at the 3-month follow-up.

    Measured: Change from baseline to 3rd month after treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Mar 2025
  2. Study start17 Mar 2025
  3. Primary completion25 Sep 2025 (estimated)
  4. Study completion30 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06888804
Sponsor's protocol ID
PTN-RF for calcaneal fracture
Status last verified
Apr 2025
First submitted
17 Mar 2025
Last updated
11 Apr 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing ultrasound-guided posterior tibial nerve pulsed radiofrequency in people with Calcaneus Fracture, run by Diskapi Teaching and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 11 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Gokhan Yildiz (5059272589, gkoyldz@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual analog scale (VAS) (time frame: Change from baseline to 3rd month after treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in